Relevantly, lower levels of insulin receptors and transporters have been found in the brain of APOE ε4 gene-targeted replacement (TR) mice and in APOE ε4 carrier AD patients compared to non-carriers, indicating hindered neuronal glucose uptake [121]. The gene discussed is APOE; the disease is Alzheimer disease.